Search Results - Alatrash, Gheath

Targeting cathepsin G in myeloid leukemia by Alatrash, Gheath

Get full text Get full text Get full text

Vaccines as consolidation therapy for myeloid leukemia by Alatrash, Gheath, Molldrem, Jeffrey J

Get full text Get full text Get full text

Immune rage against MAGE unleashed by Molldrem, Jeffrey J., Alatrash, Gheath

Get full text Get full text Get full text

Targeting PR1 in myeloid leukemia by Alatrash, Gheath, Molldrem, Jeffrey J., Qazilbash, Muzaffar H.

Get full text Get full text Get full text

Immune aspects of the breast tumor microenvironment by Chawla, Akhil, Alatrash, Gheath, Wu, Yun, Mittendorf, Elizabeth A

Get full text Get full text Get full text

Immune checkpoints: A therapeutic target in triple negative breast cancer by Chawla, Akhil, Philips, Anne V, Alatrash, Gheath, Mittendorf, Elizabeth

Get full text Get full text Get full text

Adoptive T-cell therapy for Leukemia by Garber, Haven R, Mirza, Asma, Mittendorf, Elizabeth A, Alatrash, Gheath

Get full text Get full text Get full text

Cyclic neutropenia associated with T cell immunity to granulocyte proteases and a double de novo mutation in GFI1, a transcriptional regulator of ELA2 by Armistead, Paul M., Wieder, Eric, Akande, Olanike, Alatrash, Gheath, Quintanilla, Kathryn, Liang, Shoudan, Molldrem, Jeffrey

Get full text Get full text Get full text

PR1-Specific T Cells Are Associated with Unmaintained Cytogenetic Remission of Chronic Myelogenous Leukemia After Interferon Withdrawal by Kanodia, Shreya, Wieder, Eric, Lu, Sijie, Talpaz, Moshe, Alatrash, Gheath, Clise-Dwyer, Karen, Molldrem, Jeffrey J.

Get full text Get full text Get full text

CARving the Path to Allogeneic CAR T Cell Therapy in Acute Myeloid Leukemia by Pasvolsky, Oren, Daher, May, Alatrash, Gheath, Marin, David, Daver, Naval, Ravandi, Farhad, Rezvani, Katy, Shpall, Elizabeth, Kebriaei, Partow

Get full text Get full text Get full text

Targeting human B-cell malignancies through Ig light chain specific cytotoxic T lymphocytes by Weng, Jinsheng, Cha, Soung-Chul, Matsueda, Satoko, Alatrash, Gheath, Popescu, Michael S., Yi, Qing, Molldrem, Jeffrey J, Wang, Michael, Neelapu, Sattva S., Kwak, Larry W.

Get full text Get full text Get full text

Results of a phase Ib trial of combination immunotherapy with a CD8+ T cell eliciting vaccine and trastuzumab in breast cancer patients by Clifton, G. Travis, Litton, Jennifer K., Arrington, Karen, Ponniah, Sathibalan, Ibrahim, Nuhad K., Gall, Victor, Alatrash, Gheath, Peoples, George E., Mittendorf, Elizabeth A.

Get full text Get full text Get full text

Novel myeloperoxidase-derived HLA-A2 restricted peptides as therapeutic targets against myeloid leukemia by Lu, Sijie, Tallis, Eran, Ding, Xiaoling, Li, Dan, Cox, Kathryn, You, M. James, John, Lisa St., Alatrash, Gheath, Ma, Qing, Molldrem, Jeffrey J.

Get full text Get full text Get full text

Membrane-Associated Proteinase 3 on Granulocytes and Acute Myeloid Leukemia Inhibits T Cell Proliferation by Yang, Tian-Hui, St. John, Lisa S., Garber, Haven R., Kerros, Celine, Ruisaard, Kathryn E., Clise-Dwyer, Karen, Alatrash, Gheath, Ma, Qing, Molldrem, Jeffrey J.

Get full text Get full text Get full text

Increasing Chimerism Following Allogeneic Stem Cell Transplantation is Associated with Longer Survival Time by Tang, Xiaowen, Alatrash, Gheath, Ning, Jing, Jakher, Haroon, Stafford, Patricia, Zope, Madhushree, Shpall, Elizabeth J., Jones, Roy B., Champlin, Richard E., Thall, Peter F., Andersson, Borje S.

Get full text Get full text Get full text

PR1-specific cytotoxic T lymphocytes are relatively frequent in umbilical cord blood and can be effectively expanded to target myeloid leukemia by St. John, Lisa S, Wan, Liping, He, Hong, Garber, Haven R., Clise-Dwyer, Karen, Alatrash, Gheath, Rezvani, Katayoun, Shpall, Elizabeth J., Bollard, Catherine M., Ma, Qing, Molldrem, Jeffrey J.

Get full text Get full text Get full text

An anti–PR1/HLA-A2 T-cell receptor–like antibody mediates complement-dependent cytotoxicity against acute myeloid leukemia progenitor cells by Sergeeva, Anna, Alatrash, Gheath, He, Hong, Ruisaard, Kathryn, Lu, Sijie, Wygant, James, McIntyre, Bradley W., Ma, Qing, Li, Dan, St John, Lisa, Clise-Dwyer, Karen, Molldrem, Jeffrey J.

Get full text Get full text Get full text

Common Minor Histocompatibility Antigen Discovery Based upon Patient Clinical Outcomes and Genomic Data by Armistead, Paul M., Liang, Shoudan, Li, Hua, Lu, Sijie, Van Bergen, Cornelis A. M., Alatrash, Gheath, St. John, Lisa, Hunsucker, Sally A., Sarantopoulos, Stefanie, Falkenburg, J. H. Frederik, Molldrem, Jeffrey J.

Get full text Get full text Get full text

Breast Cancer Cell Uptake of the Inflammatory Mediator Neutrophil Elastase Triggers an Anti-Cancer Adaptive Immune Response by Mittendorf, Elizabeth A., Alatrash, Gheath, Qiao, Na, Wu, Yun, Sukhumalchandra, Pariya, St John, Lisa S., Philips, Anne V., Xiao, Haile, Zhang, Mao, Ruisaard, Kathryn, Clise-Dwyer, Karen, Lu, Sijie, Molldrem, Jeffrey J.

Get full text Get full text Get full text

Circulating CD52 and CD20 levels at end of treatment predict for progression and survival in patients with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide... by Alatrash, Gheath, Albitar, Maher, O'Brien, Susan, Wang, Xuemei, Manshouri, Taghi, Faderl, Stefan, Ferrajoli, Alessandra, Burger, Jan, Garcia-Manero, Guillermo, Kantarjian, Hagop M., Lerner, Susan, Keating, Michael J., Wierda, William G.

Get full text Get full text Get full text